Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: A model of type II diabetes

Experimental Physiology

Volumn 93, Issue 2, 2008, Pages 213-222

  Morrison, John F B ^a   Shehab, Safa ^a   Sheen, Rajan ^a   Dhanasekaran, Subramanian ^a   Shaffiullah, Mohammed ^a   Mensah Brown, Eric ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; GLUCOSE; GLUTAMATE SODIUM; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ADRENAL GLAND; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVE; BODY WEIGHT; CATARACT; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETIC OBESITY; DIABETIC RETINOPATHY; DOPAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPOALGESIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NORADRENALIN BLOOD LEVEL; PANCREAS ISLET; PANCREAS ISLET BETA CELL; RAT; SENSORY NERVE; SEROTONIN BLOOD LEVEL; SPINAL CORD DORSAL HORN; THERMAL STIMULATION;

EID: 38349043995     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2007.039222     Document Type: Article

References (45)

1. Abe M, Saito M & Shimazu T (1990). Neuropeptide Y in the specific hypothalamic nuclei of rats treated neonatally with monosodium glutamate. Brain Res Bull 24, 289 291.
2. Ahmad T, Ugarph-Morawski A, Li J, Bileviciute-Ljungar I, Finn A, Ostenson CG & Kreicbergs A (2004). Bone and joint neuropathy in rats with type-2 diabetes. Regul Pept 119, 61 67.
3. Arletti R, Benelli A, Mazzaferro M, Calza L, Giardino L & Bertolini A (1993). The effect of oxytocin on feeding, drinking, and male copulatory behavior is not diminished by neonatal monosodium glutamate. Horm Behav 27, 499 510.
4. Badillo-Martinez D, Nicotera N & Bodnar RJ (1984a). Onset of pain threshold changes induced by neonatal monosodium glutamate. Int J Neurosci 24, 275 279.
5. Badillo-Martinez D, Nicotera N, Butler PD, Kirchgessner AL & Bodnar RJ (1984b). Impairments in analgesic, hypothermic, and glucoprivic stress responses following neonatal monosodium glutamate. Neuroendocrinology 38, 438 446.
6. Bodnar RJ, Abrams GM, Zimmerman EA, Krieger DT, Nicholson G & Kizer JS (1980). Neonatal monosodium glutamate. Effects upon analgesic responsivity and immunocytochemical ACTH/β-lipotropin. Neuroendocrinology 30, 280 284.
7. Bodnar I, Gooz P, Okamura H, Toth BE, Vecsernye M, Halasz B & Nagy GM (2001). Effect of neonatal treatment with monosodium glutamate on dopaminergic and L-DOPA-ergic neurons of the medial basal hypothalamus and on prolactin and MSH secretion of rats. Brain Res Bull 55, 767 774.
8. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM & Ziegler D (2005). Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956 962.
9. Calcutt NA, Stiller C, Gustafsson H & Malmberg AB (2000). Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Res 856, 20 27.
10. Cameron DP, Cutbush L & Opat F (1978). Effects of monosodium glutamate-induced obesity in mice on carbohydrate metabolism in insulin secretion. Clin Exp Pharmacol Physiol 5, 41 51.
11. de Mello MA, de Souza CT, Braga LR, dos Santos JW, Ribeiro IA & Gobatto CA (2001). Glucose tolerance and insulin action in monosodium glutamate (MSG) obese exercise-trained rats. Physiol Chem Phys Med NMR 33, 63 71.
12. de Souza CT, Nunes WM, Gobatto CA & de Mello MA (2003). Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol Chem Phys Med NMR 35, 43 53.
13. Duloo AG & Miller DS (1984). Unimpaired thermogenic response to noradrenaline in genetic (ob/ob) and hypothalamic (MSG) obese mice. Biosci Rep 4, 343 349.
14. Fernyhough P & Schmidt RE (2002). Neurofilaments in diabetic neuropathy. Int Rev Neurobiol 50, 115 144.
15. Hirata AE, Andrade IS, Vaskevicius P & Dolnikoff MS (1997). Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz J Med Biol Res 30, 671 674.
16. Kamei J, Ohhashi Y, Aoki T & Kasuya Y (1991). Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuli. Pharmacol Biochem Behav 39, 541 544.
17. Kovacs M, Halmos G, Groot K, Izdebski J & Schally AV (1996). Chronic administration of a new potent agonist of growth hormone-releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action. Neuroendocrinology 64, 169 176.
18. Kovacs M, Kineman RD, Schally AV, Flerko B & Frohman LA (2000). Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment. J Neuroendocrinol 12, 335 341.
19. Lengvari I (1977). Effect of perinatal monosodium glutamate treatment on endocrine functions of rats in maturity. Acta Biol Acad Sci Hung 28, 133 141.
20. Littlewood NK, Todd AJ, Spike RC, Watt C & Shehab SA (1995). The types of neuron in spinal dorsal horn which possess neurokinin-1 receptors. Neuroscience 66, 597 608.
21. McDaid EA, Monaghan B, Parker AI, Hayes JR & Allen JA (1994). Peripheral autonomic impairment in patients newly diagnosed with type II diabetes. Diabetes Care 17, 1422 1427.
22. Mensah-Brown EPK, Shahin A, Al-Shamisi, Wei W & Lukic ML (2006). Interleukin 23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocin. Eur J Immunol 1, 216 223.
23. Merchenthaler I, Csontos C, Kallo I & Arimura A (1986). The hypothalamo-infundibular growth hormone-releasing hormone (GH-RH) system of the rat. Brain Res 378, 297 302.
24. Miskowiak B, Kesa B, Limanowski A, Partyka M & Filipiak B (1999). Long-term effect of neonatal monosodium glutamate (MSG) treatment on reproductive system of the female rat. Folia Morph (Warsz) 58, 105 113.
25. Morrison JFB, Dhanasekaran S & Sheen R (2004). Effects of age and streptozotocin-induced diabetes on biogenic amines in rat tail artery. Mol Cell Biochem 261, 77 82.
26. Morrison JF, Howarth FC & Sheen R (2001). Catecholamines in the heart and adrenal gland of the STZ-diabetic rat. Arch Physiol Biochem 109, 206 208.
27. Moss D, Ma A & Cameron DP (1985). Defective thermoregulatory thermogenesis in monosodium glutamate-induced obesity in mice. Metabolism 34, 626 630.
28. Murakawa Y, Zhang W, Pierson CR, Brismar T, Ostenson CG, Efendic S & Sima AA (2002). Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy. Diabetes Metab Res Rev 18, 473 483.
29. Portela-Gomes GM, Grimelius L, Johansson H, Efendic S, Wester K & Abdel-Halim SM (2002). Increased expression of adenylyl cyclase isoforms in the adrenal gland of diabetic Goto-Kakizaki rat. Appl Immunohistochem Mol Morph 10, 387 392.
30. Qureshi A, Dhanasekharan S, Howarth F, Pallot D & Morrison J (1999). Hypoalgesia in the streptozotocin-treated diabetic rat. Int J Diabetes 7, 102 109.
31. Rehorek A, Kerecsen L & Muller F (1987). Measurement of tissue catecholamines of obese rats by liquid chromatography and electrochemical detection. Biomed Biochim Acta 46, 823 827.
32. Ribeiro EB, do Nascimento CM, Andrade IS, Hirata AE & Dolnikoff MS (1997). Hormonal and metabolic adaptations to fasting in monosodium glutamate-obese rats. J Comp Physiol [B] 167, 430 437.
33. Sartin JL, Lamperti AA & Kemppainen RJ (1985). Alterations in insulin and glucagon secretion by monosodium glutamate lesions of the hypothalamic arcuate nucleus. Endocr Res 11, 145 155.
34. Shehab SA, Spike RC & Todd AJ (2003). Evidence against cholera toxin B subunit as a reliable tracer for sprouting of primary afferents following peripheral nerve injury. Brain Res 964, 218 227.
35. Sima AA, Bouchier M & Christensen H (1983). Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy. Ann Neurol 13, 264 272.
36. Squibb RE, Tilson HA, Meyer OA & Lamartiniere CA (1981). Neonatal exposure to monosodium glutamate alters the neurobehavioral performance of adult rats. Neurotoxicology 2, 471 484.
37. Stricker-Krongrad A & Beck B (2004). Up-regulation of neuropeptide Y receptors in the hypothalamus of monosodium glutamate-lesioned Sprague-Dawley rats. Nutr Neurosci 7, 241 245.
38. Terenghi G, Chen S, Carrington AL, Polak JM & Tomlinson DR (1994). Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study. Acta Diabetol 31, 198 204.
39. Terry LC, Epelbaum J & Martin JB (1981). Monosodium glutamate: acute and chronic effects on rhythmic growth hormone and prolactin secretion, and somatostatin in the undisturbed male rat. Brain Res 217, 129 142.
40. Tomlinson DR, Fernyhough P & Diemel LT (1997). Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes 46 (Suppl. 2 S43 S49.
41. Toth C, Brussee V & Zochodne DW (2006). Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia 49, 1081 1088.
42. Tsukahara F, Uchida Y, Ohba K, Nomoto T & Muraki T (1997). Defective stimulation of thyroxine 5′-deiodinase activity by cold exposure and norepinephrine in brown adipose tissue of monosodium glutamate-obese mice. Horm Metab Res 29, 496 500.
43. Tsukahara F, Uchida Y, Ohba K, Ogawa A, Yoshioka T & Muraki T (1998). The effect of acute cold exposure and norepinephrine on uncoupling protein gene expression in brown adipose tissue of monosodium glutamate-obese mice. Jpn J Pharmacol 77, 247 249.
44. Yoshida T, Nishioka H, Nakamura Y & Kondo M (1984). Reduced norepinephrine turnover in mice with monosodium glutamate-induced obesity. Metabolism 33, 1060 1063.
45. Zochodne DW, Verge VM, Cheng C, Sun H & Johnston J (2001). Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. Brain 124, 2319 2334.